884 related articles for article (PubMed ID: 22634181)
1. High mobility group box 1 promotes small intestinal damage induced by nonsteroidal anti-inflammatory drugs through Toll-like receptor 4.
Nadatani Y; Watanabe T; Tanigawa T; Machida H; Okazaki H; Yamagami H; Watanabe K; Tominaga K; Fujiwara Y; Arakawa T
Am J Pathol; 2012 Jul; 181(1):98-110. PubMed ID: 22634181
[TBL] [Abstract][Full Text] [Related]
2. High-mobility group box-1 in ischemia-reperfusion injury of the heart.
Andrassy M; Volz HC; Igwe JC; Funke B; Eichberger SN; Kaya Z; Buss S; Autschbach F; Pleger ST; Lukic IK; Bea F; Hardt SE; Humpert PM; Bianchi ME; Mairbäurl H; Nawroth PP; Remppis A; Katus HA; Bierhaus A
Circulation; 2008 Jun; 117(25):3216-26. PubMed ID: 18574060
[TBL] [Abstract][Full Text] [Related]
3. Non-steroidal anti-inflammatory drug-induced small intestinal damage is Toll-like receptor 4 dependent.
Watanabe T; Higuchi K; Kobata A; Nishio H; Tanigawa T; Shiba M; Tominaga K; Fujiwara Y; Oshitani N; Asahara T; Nomoto K; Takeuchi K; Arakawa T
Gut; 2008 Feb; 57(2):181-7. PubMed ID: 17639086
[TBL] [Abstract][Full Text] [Related]
4. Targeting high mobility group box protein 1 ameliorates testicular inflammation in experimental autoimmune orchitis.
Aslani F; Schuppe HC; Guazzone VA; Bhushan S; Wahle E; Lochnit G; Lustig L; Meinhardt A; Fijak M
Hum Reprod; 2015 Feb; 30(2):417-31. PubMed ID: 25452436
[TBL] [Abstract][Full Text] [Related]
5. High-mobility group box 1 inhibits gastric ulcer healing through Toll-like receptor 4 and receptor for advanced glycation end products.
Nadatani Y; Watanabe T; Tanigawa T; Ohkawa F; Takeda S; Higashimori A; Sogawa M; Yamagami H; Shiba M; Watanabe K; Tominaga K; Fujiwara Y; Takeuchi K; Arakawa T
PLoS One; 2013; 8(11):e80130. PubMed ID: 24244627
[TBL] [Abstract][Full Text] [Related]
6. Extracellular high mobility group box-1 inhibits R5 and X4 HIV-1 strains replication in mononuclear phagocytes without induction of chemokines and cytokines.
Cassetta L; Fortunato O; Adduce L; Rizzi C; Hering J; Rovere-Querini P; Bianchi ME; Alfano M; Poli G
AIDS; 2009 Mar; 23(5):567-77. PubMed ID: 19194273
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effects of lycopene on HMGB1-mediated pro-inflammatory responses in both cellular and animal models.
Lee W; Ku SK; Bae JW; Bae JS
Food Chem Toxicol; 2012 Jun; 50(6):1826-33. PubMed ID: 22429818
[TBL] [Abstract][Full Text] [Related]
8. Convergence and amplification of toll-like receptor (TLR) and receptor for advanced glycation end products (RAGE) signaling pathways via high mobility group B1 (HMGB1).
van Beijnum JR; Buurman WA; Griffioen AW
Angiogenesis; 2008; 11(1):91-9. PubMed ID: 18264787
[TBL] [Abstract][Full Text] [Related]
9. RAGE is the major receptor for the proinflammatory activity of HMGB1 in rodent macrophages.
Kokkola R; Andersson A; Mullins G; Ostberg T; Treutiger CJ; Arnold B; Nawroth P; Andersson U; Harris RA; Harris HE
Scand J Immunol; 2005 Jan; 61(1):1-9. PubMed ID: 15644117
[TBL] [Abstract][Full Text] [Related]
10. The HMGB1-TLR4 axis contributes to myocardial ischemia/reperfusion injury via regulation of cardiomyocyte apoptosis.
Ding HS; Yang J; Chen P; Yang J; Bo SQ; Ding JW; Yu QQ
Gene; 2013 Sep; 527(1):389-93. PubMed ID: 23727604
[TBL] [Abstract][Full Text] [Related]
11. Anti-high mobility group box-1 antibody therapy for traumatic brain injury.
Okuma Y; Liu K; Wake H; Zhang J; Maruo T; Date I; Yoshino T; Ohtsuka A; Otani N; Tomura S; Shima K; Yamamoto Y; Yamamoto H; Takahashi HK; Mori S; Nishibori M
Ann Neurol; 2012 Sep; 72(3):373-84. PubMed ID: 22915134
[TBL] [Abstract][Full Text] [Related]
12. The role of Toll-like receptor proteins (TLR) 2 and 4 in mediating inflammation in proximal tubules.
Mudaliar H; Pollock C; Komala MG; Chadban S; Wu H; Panchapakesan U
Am J Physiol Renal Physiol; 2013 Jul; 305(2):F143-54. PubMed ID: 23576640
[TBL] [Abstract][Full Text] [Related]
13. High mobility group box 1 activates Toll like receptor 4 signaling in hepatic stellate cells.
Zhang Z; Lin C; Peng L; Ouyang Y; Cao Y; Wang J; Friedman SL; Guo J
Life Sci; 2012 Sep; 91(5-6):207-12. PubMed ID: 22841886
[TBL] [Abstract][Full Text] [Related]
14. HMGB1 signals through toll-like receptor (TLR) 4 and TLR2.
Yu M; Wang H; Ding A; Golenbock DT; Latz E; Czura CJ; Fenton MJ; Tracey KJ; Yang H
Shock; 2006 Aug; 26(2):174-9. PubMed ID: 16878026
[TBL] [Abstract][Full Text] [Related]
15. The role of MAPK in Kupffer cell toll-like receptor (TLR) 2-, TLR4-, and TLR9-mediated signaling following trauma-hemorrhage.
Thobe BM; Frink M; Hildebrand F; Schwacha MG; Hubbard WJ; Choudhry MA; Chaudry IH
J Cell Physiol; 2007 Mar; 210(3):667-75. PubMed ID: 17117477
[TBL] [Abstract][Full Text] [Related]
16. HMGB1: the missing link between diabetes mellitus and heart failure.
Volz HC; Seidel C; Laohachewin D; Kaya Z; Müller OJ; Pleger ST; Lasitschka F; Bianchi ME; Remppis A; Bierhaus A; Katus HA; Andrassy M
Basic Res Cardiol; 2010 Nov; 105(6):805-20. PubMed ID: 20703492
[TBL] [Abstract][Full Text] [Related]
17. Toll-like receptor (TLR) 2 agonists ameliorate indomethacin-induced murine ileitis by suppressing the TLR4 signaling.
Narimatsu K; Higashiyama M; Kurihara C; Takajo T; Maruta K; Yasutake Y; Sato H; Okada Y; Watanabe C; Komoto S; Tomita K; Nagao S; Miura S; Hokari R
J Gastroenterol Hepatol; 2015 Nov; 30(11):1610-7. PubMed ID: 25867219
[TBL] [Abstract][Full Text] [Related]
18. Nuclear factor high-mobility group box1 mediating the activation of Toll-like receptor 4 signaling in hepatocytes in the early stage of nonalcoholic fatty liver disease in mice.
Li L; Chen L; Hu L; Liu Y; Sun HY; Tang J; Hou YJ; Chang YX; Tu QQ; Feng GS; Shen F; Wu MC; Wang HY
Hepatology; 2011 Nov; 54(5):1620-30. PubMed ID: 21809356
[TBL] [Abstract][Full Text] [Related]
19. [Effect of high mobility group box 1 (HMGB1) in cultured human periodontal ligament cells].
Hasegawa N
Kokubyo Gakkai Zasshi; 2008 Oct; 75(3):155-61. PubMed ID: 19044016
[TBL] [Abstract][Full Text] [Related]
20. Receptor for advanced glycation end products and its ligand high-mobility group box-1 mediate allergic airway sensitization and airway inflammation.
Ullah MA; Loh Z; Gan WJ; Zhang V; Yang H; Li JH; Yamamoto Y; Schmidt AM; Armour CL; Hughes JM; Phipps S; Sukkar MB
J Allergy Clin Immunol; 2014 Aug; 134(2):440-50. PubMed ID: 24506934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
